These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 3167850

  • 21. Successful treatment of murine melanoma with bryostatin 1.
    Schuchter LM, Esa AH, May S, Laulis MK, Pettit GR, Hess AD.
    Cancer Res; 1991 Jan 15; 51(2):682-7. PubMed ID: 1985785
    [Abstract] [Full Text] [Related]

  • 22. Specific protein phosphorylation in human promyelocytic HL-60 leukemia cells susceptible or resistant to induction of cell differentiation by phorbol-12-myristate-13-acetate.
    Anderson NL, Gemmell MA, Coussens PM, Murao S, Huberman E.
    Cancer Res; 1985 Oct 15; 45(10):4955-62. PubMed ID: 3861240
    [Abstract] [Full Text] [Related]

  • 23. Structure of bryostatin 20: a symbiont-produced chemical defense for larvae of the host bryozoan, Bugula neritina.
    Lopanik N, Gustafson KR, Lindquist N.
    J Nat Prod; 2004 Aug 15; 67(8):1412-4. PubMed ID: 15332866
    [Abstract] [Full Text] [Related]

  • 24. Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro.
    Jones RJ, Sharkis SJ, Miller CB, Rowinsky EK, Burke PJ, May WS.
    Blood; 1990 Mar 15; 75(6):1319-23. PubMed ID: 2310830
    [Abstract] [Full Text] [Related]

  • 25. Phosphorylation of lamin B at the nuclear membrane by activated protein kinase C.
    Fields AP, Pettit GR, May WS.
    J Biol Chem; 1988 Jun 15; 263(17):8253-60. PubMed ID: 3163693
    [Abstract] [Full Text] [Related]

  • 26. Effect of pharmacologic manipulation of protein kinase C by phorbol dibutyrate and bryostatin 1 on the clonogenic response of human granulocyte-macrophage progenitors to recombinant GM-CSF.
    McCrady CW, Staniswalis J, Pettit GR, Howe C, Grant S.
    Br J Haematol; 1991 Jan 15; 77(1):5-15. PubMed ID: 1998597
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Bistratene A: a novel compound causing changes in protein phosphorylation patterns in human leukemia cells.
    Watters DJ, Michael J, Hemphill JE, Hamilton SE, Lavin MF, Pettit GR.
    J Cell Biochem; 1992 Aug 15; 49(4):417-24. PubMed ID: 1429868
    [Abstract] [Full Text] [Related]

  • 29. Modulation of the expression of Bcl-2 and related proteins in human leukemia cells by protein kinase C activators: relationship to effects on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis.
    Bartimole TM, Vrana JA, Freemerman AJ, Jarvis WD, Reed JC, Boise LH, Grant S.
    Cell Death Differ; 1997 May 15; 4(4):294-303. PubMed ID: 16465244
    [Abstract] [Full Text] [Related]

  • 30. Bryostatin-1 stimulates the transcription of cyclooxygenase-2: evidence for an activator protein-1-dependent mechanism.
    De Lorenzo MS, Yamaguchi K, Subbaramaiah K, Dannenberg AJ.
    Clin Cancer Res; 2003 Oct 15; 9(13):5036-43. PubMed ID: 14581379
    [Abstract] [Full Text] [Related]

  • 31. Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors.
    Thijsen SF, Schuurhuis GJ, van Oostveen JW, Theijsmeijer AP, van der Hem KG, Odding JH, Dräger AM, Ossenkoppele GJ.
    Br J Cancer; 1999 Mar 15; 79(9-10):1406-12. PubMed ID: 10188883
    [Abstract] [Full Text] [Related]

  • 32. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A, Mohammad RM, Dan M, Hussein ME, Akhtar A, Pettit GR, Sensenbrenner LL.
    Exp Hematol; 1993 Jan 15; 21(1):61-5. PubMed ID: 8093352
    [Abstract] [Full Text] [Related]

  • 33. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
    Chelliah J, Freemerman AJ, Wu-Pong S, Jarvis WD, Grant S.
    Biochem Pharmacol; 1997 Sep 01; 54(5):563-73. PubMed ID: 9337072
    [Abstract] [Full Text] [Related]

  • 34. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
    Mohammad RM, Varterasian ML, Almatchy VP, Hannoudi GN, Pettit GR, Al-Katib A.
    Clin Cancer Res; 1998 May 01; 4(5):1337-43. PubMed ID: 9607595
    [Abstract] [Full Text] [Related]

  • 35. Bryostatin 1 induces biphasic activation of protein kinase D in intact cells.
    Matthews SA, Pettit GR, Rozengurt E.
    J Biol Chem; 1997 Aug 08; 272(32):20245-50. PubMed ID: 9242703
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin.
    Hennings H, Blumberg PM, Pettit GR, Herald CL, Shores R, Yuspa SH.
    Carcinogenesis; 1987 Sep 08; 8(9):1343-6. PubMed ID: 3621472
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.